Abiopharma

🔍 Brazier Mark Christopher (Executive)

Company: Forward Industries, Inc. (FWDI)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 275,000 shares of Common Stock (Direct)
  Date: 2026-04-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 275,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 275,000 shares of Stock Options (Right to Buy) (Derivative)
  Date: 2026-04-16 | Code: A | Expires: 2036-04-16 | equity_swap_involved: 0 | shares_owned_after: 275,000.00 | transaction_form_type: 4 | Footnotes: F2, F4, F5, F3

Footnotes:

• F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon vesting.
• F2: The grant of restricted stock units and stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The restricted stock units and stock options were granted under the Issuer's 2021 Equity Incentive Plan.
• F3: The securities vest as follows: 25% on April 13, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter, subject to continued service with the Issuer on each applicable vesting date.
• F4: One-half of the stock options have an exercise price per share of $9.18 and the remaining one-half of the stock options have an exercise price per share of $13.77.
• F5: Not applicable.